pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
EMERGENT · news · pharmadog
← back to EMERGENT
News mentioning EMERGENT
33
stories
2d
Longeveron’s shares crash as stem cell therapy flunks mid-stage cardio trial
biospace
2d
Longeveron’s phase 2b stem cell flop spurs cost cutting, exploration of ‘all options’
fiercebiotech
3d
Sling catches $123M series C for thyroid eye disease pill
biospace
5d
Summit, BioNTech, more headline WCLC with next-gen lung cancer drugs
biospace
5d
Definium moves toward FDA submission for LSD drug in anxiety after ‘another clear win’
biospace
10d
Tyra rolls toward pivotal bladder cancer study even as midphase data deflates stock
fiercebiotech
11d
Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancer
biospace
11d
FDA approves AstraZeneca’s Etcamah, opening ctDNA-guided treatment paradigm in breast cancer
fiercebiotech
16d
AbbVie’s bispecific T-cell engager shows promise in ph. 3 multiple myeloma trial
fiercebiotech
19d
Arrowhead's new Redemplo findings in severe hypertriglyceridemia have analysts split
biospace
23d
Generate Bio drops as data accidentally leaked ahead of European conference
biospace
Aug 17, 26
Intraosseous Needle Set Recall: Becton Dickinson Removes Certain Intraosseous Vascular Access System Needle Sets
fda medwatch
Aug 10, 26
As BMS’ Cobenfy struggles to gain traction, MapLight knocks on the door
biospace
Aug 6, 26
Sarepta pushes back Elevidys timeline; Emergent lays off 90 staffers
endpoints
Aug 5, 26
Narcan maker Emergent BioSolutions eliminates top R&D role in sweeping restructuring
fiercebiotech
Aug 4, 26
Early Alert: Intraosseous Needle Set Issue from Becton Dickinson
fda medwatch
Jul 29, 26
MapLight CEO on what investors missed in the biotech’s schizophrenia data
biopharma dive
Jul 27, 26
MapLight dives despite positive data for schizophrenia drug
biopharma dive
Jul 27, 26
MapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout
biospace
Jul 22, 26
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 17, 26
FDA Approves First Single-Dose Generic Treatment for Influenza
fda press
Jun 5, 26
Study data convince Lundbeck to push new migraine drug forward
biopharma dive
Jun 5, 26
Opinion: How living and practicing medicine abroad complicated my beliefs about universal health care systems
stat
Jun 1, 26
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
stat
May 13, 26
Dr Bockorny on the Rationale for Targeting CCR8 in Solid Tumors
onclive
May 12, 26
Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Cancer
onclive
May 12, 26
Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanoma
onclive
May 12, 26
Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanoma
onclive
May 8, 26
Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026
onclive
← prev
page 1 of 2
next →
